Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 21:00 source : Www.sutrobio.com save search
Sutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer
Published: 2023-04-27 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -0.69%
H: 1.16%
C: -1.39%
biopharma research
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
Published: 2023-03-30 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -0.89%
H: 6.31%
C: 4.05%
business year biopharma financial
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-02-17 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
| Email alert
Add to watchlist
biopharma nasdaq grants
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
Published: 2022-08-08 (Crawled : 21:00) - sutrobio.com
PCVX | $62.45 0.34% 0.34% 690K
|
Health Technology
|
| O: -0.23%
H: 1.12%
C: 0.66%
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -0.48%
H: 14.98%
C: 7.14%
biopharma
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-06-03 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
| Email alert
Add to watchlist
biopharma nasdaq grants
Bill Newell, CEO Interviewed by Dr. Michelle McMurry-Heath on I Am Bio Podcast, Episode 73 – “Investors Become Goldilocks in a Bear Market”
Published: 2022-06-02 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 4.18%
H: 0.0%
C: 0.0%
ceo
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
Published: 2022-05-09 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 4.57%
H: 5.99%
C: 1.33%
biopharma
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-04-29 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
| Email alert
Add to watchlist
biopharma nasdaq grant
12th Annual World ADC London 2022 – Presentations
Published: 2022-03-30 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 0.61%
H: 5.49%
C: 0.37%
Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC
Published: 2022-03-30 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 0.61%
H: 5.49%
C: 0.37%
biopharma drug antibody
Scientist, Cell Biology
Published: 2021-09-27 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -1.14%
H: 0.37%
C: -1.57%
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-09-17 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
| Email alert
Add to watchlist
biopharma granted grant
Senior Scientist, Protein Engineering
Published: 2021-08-06 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
| Email alert
Add to watchlist
Director, Regulatory Affairs CMC
Published: 2021-07-30 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
| Email alert
Add to watchlist
Jefferies Virtual Healthcare Conference 2021 – Presentation
Published: 2021-06-02 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -0.94%
H: 2.97%
C: 1.96%
presentation conference
Sutro Biopharma Announces Additional Data for Dose-Escalation Phase 1 Study of STRO-002 to be Presented at ASCO 2021
Published: 2021-05-19 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 1.58%
H: 2.43%
C: -10.66%
biopharma phase 1 phase 3 phase 2
American Society of Clinical Oncology (ASCO) Virtual Annual Meeting 2021 – STRO-002 – Abstract
Published: 2021-05-19 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 1.58%
H: 2.43%
C: -10.66%
Manager, Contracts Administration & Legal Affairs
Published: 2021-05-05 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -1.6%
H: 2.51%
C: -2.99%
contract
Corporate Counsel
Published: 2021-04-27 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -0.83%
H: 4.02%
C: 2.79%
Senior Research Associate, Bioanalytical
Published: 2021-03-30 (Crawled : 21:00) - sutrobio.com
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: 1.43%
H: 7.69%
C: 6.65%
research
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.